Clinical trial
Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs…
NCT00161824 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00161824 |
|---|---|
| Title | Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR |
| Official title | Single-blind, Randomized, Multicenter Comparison of FSME IMMUN NEW and ENCEPUR: Safety and Tolerability of Two Vaccinations in Healthy Volunteers Aged 16 to 65 Years. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Encephalitis, Tick-borne |
| Intervention type | Biological |
| Interventions | Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) |
| Enrollment | 3,800 |
| Start date | Oct 1, 2001 |
| Completion | Jan 1, 2002 |
| First posted | Sep 13, 2005 |
| Last update posted | May 21, 2015 |
| Countries | Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: